Amphetamine-Induced Displacement of [18F] Fallypride in Striatum and Extrastriatal Regions in Humans
The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Abstract
This study examined D-amphetamine (D-AMPH)-induced displacements of [18F] fallypride in striatal and extrastriatal regions and the correlations of these displacements with cognition, affect, and sensation-seeking behavior. In all, 14 normal subjects, six females and eight males (ages 21-32, mean age 25.9 years), underwent positron emission tomography (PET) with [18F]fallypride before and 3 h after a 0.43 mg/kg oral dose of D-AMPH. Levels of dopamine (DA) D2 receptor density were calculated with the reference region method of Lammerstma. Percent displacements in striatal and extrastriatal regions were calculated for the caudate, putamen, ventral striatum, medial thalamus, amygdala, substantia nigra, and temporal cortex. Correlations of changes in cognition, affect, and sensation seeking with parametric images of D-AMPH-induced DA release were computed. Significant displacements were seen in the caudate, putamen, ventral striatum substantia nigra, and temporal cortex with a trend level change in the amygdala. Greatest displacements were seen in striatal subdivisions-5.6% in caudate, 11.2% in putamen, 7.2% in ventral striatum, and 6.6% in substantia nigra. Lesser decrements were seen in amygdala-4.4%, temporal cortex-3.7%, and thalamus-2.8%. Significant clusters of correlations of regional DA release with cognition and sensation-seeking behavior were observed. The current study demonstrates that [18F]fallypride PET studies using oral D-AMPH (0.43 mg/kg) can be used to study D-AMPH-induced DA release in the striatal and extrastriatal regions in humans, and their relationship with cognition and sensation-seeking behavior.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Development and validation of brief measures of positive and negative affect: The PANAS scales.
Watson, D., Clark, L. A., & Tellegen, A. (1988) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.54.6.1063 · Cited by 32,433
Wechsler Adult Intelligence Scale-III
Ryan, J. J., & Lopez, S. J. (2001) · Understanding Psychological Assessment · doi:10.1007/978-1-4615-1185-4_2 · Cited by 3,731
Forman, S. D., Cohen, J. D., Fitzgerald, M., Eddy, W. F., Mintun, M. A., & Noll, D. C. (1995) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910330508 · Cited by 3,202
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
Sensation seeking in England and America: cross-cultural, age, and sex comparisons
Zuckerman, M., Eysenck, S. B., & Eysenck, H. J. (1978) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.46.1.139 · Cited by 1,905
The Structured Clinical Interview for DSM-III-R (SCID): II. Multisite Test-Retest Reliability
Williams, J. B. W. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820080038006 · Cited by 1,618
D1 Dopamine Receptors in Prefrontal Cortex: Involvement in Working Memory
Sawaguchi, T., & Goldman-Rakic, P. S. (1991) · Science · doi:10.1126/science.1825731 · Cited by 1,364 · cited 2×
“Frontal cortical dopaminergic neurotransmission has been shown to modulate spatial working memory (Sawaguchi and Goldman-Rakic, 1991).”
BackgroundLaruelle, M., Abi-Dargham, A., van Dyck, C. H., Gil, R., D'Souza, C. D., Erdos, J., McCance, E., Rosenblatt, W., Fingado, C., Zoghbi, S. S., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9235 · Cited by 1,291 · cited 2×
“[123I]IBZM SPECT studies of D-AMPH-induced displacements report decrements in the striatum of 7–9% in normal subjects following an intravenous dose of 0.3mg/kg (Abi-Dargham et al, 2003, 2004; Laruelle et al, 1996; Kegeles et al, 1999).”
BackgroundInfluentialSelf-citationBreier, A., Su, T.-P., Saunders, R., Carson, R. E., Kolachana, B. S., de Bartolomeis, A., Weinberger, D. R., Weisenfeld, N., Malhotra, A. K., Eckelman, W. C., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2569 · Cited by 1,154 · cited 3×
“The decrement in striatal binding potential (b.p.) or V300 for benzamide DA D2/D3 radioligands following D-AMPH administration in primates has been shown to be linearly related to the level of D-AMPH-induced DA release (Laruelle et al, 1997; Breier et al, 1997).”
BackgroundInfluentialDopamine in drug abuse and addiction: results from imaging studies and treatment implications
Volkow, N. D., Fowler, J. S., Wang, G.-J., & Swanson, J. M. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001507 · Cited by 1,101 · cited 6×
“014), substantia nigra (p¼ 0.014), and temporal cortex (po0.”
BackgroundResultInfluentialAtlas for Stereotaxy of the Human Brain
Schaltenbrand, G., & Wahren, W. (1977) · Medical Entomology and Zoology · Cited by 955
Imaging Synaptic Neurotransmission with in Vivo Binding Competition Techniques: A Critical Review
Laruelle, M. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00001 · Cited by 944
Comparison and Evaluation of Retrospective Intermodality Brain Image Registration Techniques
West, J., Fitzpatrick, J. M., Wang, M. Y., Dawant, B. M., Maurer, C. R., Kessler, R. M., Maciunas, R. J., Barillot, C., Lemoine, D., Collignon, A., et al. (1997) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199707000-00007 · Cited by 884
Self-citationAtlas for stereotaxy of the human brain
Bosch, D. A. (1978) · Clinical Neurology and Neurosurgery · doi:10.1016/s0303-8467(78)80027-4 · Cited by 867
Increased Striatal Dopamine Transmission in Schizophrenia: Confirmation in a Second Cohort
Abi-Dargham, A., Gil, R., Krystal, J., Baldwin, R. M., Seibyl, J. P., Bowers, M., van Dyck, C. H., Charney, D. S., Innis, R. B., & Laruelle, M. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.6.761 · Cited by 803
Self-citationPrefrontal neurons and the genetics of schizophrenia
Weinberger, D. R., Egan, M. F., Bertolino, A., Callicott, J. H., Mattay, V. S., Lipska, B. K., Berman, K. F., & Goldberg, T. E. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01252-5 · Cited by 741
Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria
Drevets, W. C., Gautier, C., Price, J. C., Kupfer, D. J., Kinahan, P. E., Grace, A. A., Price, J. L., & Mathis, C. A. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01038-6 · Cited by 706 · cited 15×
“Changes in performance on the Digit Symbol Coding, a test of attention, and speed of cognitive processing, were significantly correlated with a cluster centered in the right ventral striatum, but involving the right and left ventral striatum and basal forebrain (po0.”
BackgroundMethodResultInfluentialMartinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.-R., Huang, Y., Cooper, T., Kegeles, L., Zarahn, E., Abi-Dargham, A., et al. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000048520.34839.1a · Cited by 569
Yung, K. K. L., Bolam, J. P., Smith, A. D., Hersch, S. M., Ciliax, B. J., & Levey, A. I. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00536-e · Cited by 542
Mawlawi, O., Martinez, D., Slifstein, M., Broft, A., Chatterjee, R., Hwang, D.-R., Huang, Y., Simpson, N., Ngo, K., Van Heertum, R., et al. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00002 · Cited by 525 · cited 2×
“To make the results comparable to the study of Martinez et al, 2003, we used the same anatomic criteria for delineation of the ventral striatum as used in that study (Mawlawi et al, 2001).”
MethodResultLeyton, M. (2002) · Neuropsychopharmacology · doi:10.1016/s0893-133x(02)00366-4 · Cited by 476
Sesack, Sr., Aoki, C., & Pickel, V. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00088.1994 · Cited by 461 · cited 3×
“In the substantia nigra, DA D2 receptors are autoreceptors which are localized on the dendrites of dopaminergic neurons (Sesack et al, 1994) and are in the high-affinity agonist state, while in the striatum they are in both the high- and low-affinity state.”
BackgroundInfluentialComparison of Methods for Analysis of Clinical [11C]Raclopride Studies
Lammertsma, A. A., Bench, C. J., Hume, S. P., Osman, S., Gunn, K., Brooks, D. J., & Frackowiak, R. S. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199601000-00005 · Cited by 459
Garris, P., & Wightman, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-01-00442.1994 · Cited by 418
WECHSLER ADULT INTELLIGENCE SCALE
Maharani, N. D., Maulidyah A.R, N. A., Maghfiroh, N. A., & Eva, N. (2021) · Flourishing Journal · doi:10.17977/um070v2i12022p32-37 · Cited by 417
Abi-Dargham, A., Krystal, J. H., Anjilvel, S., Scanley, B. E., Zoghbi, S., Baldwin, R. M., Rajeevan, N., Ellis, S., Petrakis, I. L., Seibyl, J. P., et al. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.11.1550 · Cited by 405
Self-citationThe adaptive bases algorithm for intensity-based nonrigid image registration
Rohde, G. K., Aldroubi, A., & Dawant, B. M. (2003) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2003.819299 · Cited by 402
Self-citationThe Cortical Dopamine System: Role in Memory and Cognition
(1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60846-7 · Cited by 394
Imaging endogenous dopamine competition with [11C]raclopride in the human brain
Volkow, N. D., Wang, G., Fowler, J. S., Logan, J., Schlyer, D., Hitzemann, R., Lieberman, J., Angrist, B., Pappas, N., MacGregor, R., et al. (1994) · Synapse · doi:10.1002/syn.890160402 · Cited by 379 · cited 1×
“Several brain imaging studies have investigated D-amphetamine (D-AMPH)-induced dopamine (DA) release in the striatum (Laruelle et al, 1995; Kegeles et al, 1999; Drevets et al, 2001; Singer et al, 2002; Piccini et al, 2003; Martinez et al, 2003; Volkow et al, 1994, 2004).”
BackgroundGABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex
Carr, D. B., & Sesack, S. R. (2000) · Synapse · doi:10.1002/1098-2396(200011)38:2<114::aid-syn2>3.0.co;2-r · Cited by 352
SPECT imaging of striatal dopamine release after amphetamine challenge.
Laruelle, M. A., Abi‐Dargham, A., van Dyck, C. H., Rosenblatt, W., Zea‐Ponce, Y., Zoghbi, S. S., Baldwin, R. M., Charney, D. S., Hoffer, P. B., & Kung, H. F. (1995) · PubMed · Cited by 333
Self-citationPiazza, P. V., Rougé-Pont, F., Deminière, J. M., Kharoubi, M., Le Moal, M., & Simon, H. (1991) · Brain Research · doi:10.1016/0006-8993(91)91452-7 · Cited by 332
Aalto, S., Brück, A., Laine, M., Någren, K., & Rinne, J. O. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2097-04.2005 · Cited by 284
Mukherjee, J., Christian, B. T., Dunigan, K. A., Shi, B., Narayanan, T. K., Satter, M., & Mantil, J. (2002) · Synapse · doi:10.1002/syn.10128 · Cited by 270
Comparison and evaluation of retrospective intermodality image registration techniques:
West, J. B., Fitzpatrick, J. M., Wang, M. Y., Dawant, B. M., Maurer, Jr., Kessler, R. M., Maciunas, R. J., Barillot, C., Lemoine, D., Collignon, A. M. F., et al. (1996) · SPIE Proceedings · doi:10.1117/12.237936 · Cited by 269
Self-citationMicrodialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates
Laruelle, M., Iyer, R. N., Al-Tikriti, M. S., Zea-Ponce, Y., Malison, R., Zoghbi, S. S., Baldwin, R. M., Kung, H. F., Charney, D. S., Hoffer, P. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199701)25:1<1::aid-syn1>3.0.co;2-h · Cited by 265
Self-citationElevated Intrasynaptic Dopamine Release in Tourette’s Syndrome Measured by PET
Singer, H. S., Szymanski, S., Giuliano, J., Yokoi, F., Dogan, A. S., Brasic, J. R., Zhou, Y., Grace, A. A., & Wong, D. F. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.8.1329 · Cited by 259
Marinelli, M., & White, F. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-23-08876.2000 · Cited by 254
The Theory and Practice of 3D PET
(1998) · Springer eBooks · doi:10.1007/978-94-017-3475-2 · Cited by 223
Mehta, M. A., Sahakian, B. J., McKenna, P. J., & Robbins, T. W. (1999) · Psychopharmacology · doi:10.1007/s002130051102 · Cited by 223
Carbon-11-FLB 457: a radioligand for extrastriatal D2 dopamine receptors.
Halldin, C., Farde, L., Högberg, T., Mohell, N., Hall, H., Suhara, T., Karlsson, P., Nakashima, Y., & Swahn, C. (1995) · PubMed · Cited by 223
Mukherjee, J., Yang, Z.-Y., Das, M. K., & Brown, T. (1995) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)00117-3 · Cited by 219
Dendrodendritic Inhibition Through Reversal of Dopamine Transport
Falkenburger, B. H., Barstow, K. L., & Mintz, I. M. (2001) · Science · doi:10.1126/science.1060645 · Cited by 214
Decreased Dopamine D2 Receptor Binding in the Anterior Cingulate Cortex in Schizophrenia
Suhara, T., Okubo, Y., Yasuno, F., Sudo, Y., Inoue, M., Ichimiya, T., Nakashima, Y., Nakayama, K., Tanada, S., Suzuki, K., et al. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.1.25 · Cited by 194
Cragg, S. J., & Greenfield, S. A. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-15-05738.1997 · Cited by 184
Farde, L., Suhara, T., Karlsson, P., Hietala, J., Nakashima, Y., Halldin, C., & Nyberg, S. (1997) · Psychopharmacology · doi:10.1007/s002130050420 · Cited by 177
Quantification of [11C]FLB 457 Binding to Extrastriatal Dopamine Receptors in the Human Brain
Olsson, H., Halldin, C., Swahn, C.-G., & Farde, L. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199910000-00013 · Cited by 174
Limbic selectivity of clozapine
Pilowsky, L. S., Mulligan, R. S., Acton, P. D., Ell, P. J., Costa, D. C., & Kerwin, R. W. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63079-6 · Cited by 173
Early pharmacokinetics and clinical effects of oral d-amphetamine in normal subjects
Angrist, B., Corwin, J., Bartlik, B., & Cooper, T. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90070-9 · Cited by 171
Xiberas, X., Martinot, J. L., Mallet, L., Artiges, E., Loc'h, C., Mazière, B., & Paillère-Martinot, M. L. (2001) · British Journal of Psychiatry · doi:10.1192/bjp.179.6.503 · Cited by 171
Lawrence, A. (1998) · Brain · doi:10.1093/brain/121.7.1343 · Cited by 170
Clinical and psychometric correlates of dopamine D2 binding in depression
SHAH, P. J., OGILVIE, A. D., GOODWIN, G. M., & EBMEIER, K. P. (1997) · Psychological Medicine · doi:10.1017/s0033291797005382 · Cited by 170
Hooks, M., Juncos, J., Justice, J., Meiergerd, S., Povlock, S., Schenk, J., & Kalivas, P. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-10-06144.1994 · Cited by 164
In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.
Kung, H. F., Pan, S., Kung, M., Billings, J. J., Kasliwal, R., Reilley, J., & Alavi, A. A. (1989) · PubMed · Cited by 163
Spatial working memory deficits and clinical symptoms in schizophrenia: a 4-month follow-up study
Park, S., Püschel, J., Sauter, B. H., Rentsch, M., & Hell, D. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00370-9 · Cited by 161
Self-citationKessler, R. M., Whetsell, W. O., Sib Ansari, M., Votaw, J. R., de Paulis, T., Clanton, J. A., Schmidt, D. E., Scott Mason, N., & Manning, R. G. (1993) · Brain Research · doi:10.1016/0006-8993(93)90878-q · Cited by 159
Self-citationNarendran, R., Hwang, D., Slifstein, M., Talbot, P. S., Erritzoe, D., Huang, Y., Cooper, T. B., Martinez, D., Kegeles, L. S., Abi‐Dargham, A., et al. (2004) · Synapse · doi:10.1002/syn.20013 · Cited by 157
Cragg, S. J., Nicholson, C., Kume-Kick, J., Tao, L., & Rice, M. E. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.85.4.1761 · Cited by 150
Personality traits and brain dopaminergic function in Parkinson's disease
Kaasinen, V., Nurmi, E., Bergman, J., Eskola, O., Solin, O., Sonninen, P., & Rinne, J. O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231313198 · Cited by 148 · cited 2×
“Correlations of changes in cognition, affect, and sensation seeking with parametric images of D-AMPH-induced DA release were computed.”
BackgroundMethodEndogenous dopamine release after pharmacological challenges in Parkinson's disease
Piccini, P., Pavese, N., & Brooks, D. J. (2003) · Annals of Neurology · doi:10.1002/ana.10526 · Cited by 147
Mutual information matching in multiresolution contexts
Pluim, J. P. W., Maintz, J. B. A., & Viergever, M. A. (2001) · Image and Vision Computing · doi:10.1016/s0262-8856(00)00054-8 · Cited by 142
Heeringa, M. J., & Abercrombie, E. D. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010192.x · Cited by 142
Mukherjee, J., Yang, Z.-Y., Brown, T., Lew, R., Wernick, M. N., Ouyang, X., Yasillo, N. J., Chen, C.-T., Mintzer, R. A., & Cooper, M. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00012-8 · Cited by 141
Abi-Dargham, A., Kegeles, L. S., Zea-Ponce, Y., Mawlawi, O., Martinez, D., Mitropoulou, V., O'Flynn, K., Koenigsberg, H. W., Van Heertum, R., Cooper, T., et al. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.018 · Cited by 128
Tsukada, H., Nishiyama, S., Kakiuchi, T., Ohba, H., Sato, K., Harada, N., & Nakanishi, S. (1999) · Brain Research · doi:10.1016/s0006-8993(99)02018-1 · Cited by 124
Low Dopamine D2Receptor Binding in Subregions of the Thalamus in Schizophrenia
Yasuno, F., Suhara, T., Okubo, Y., Sudo, Y., Inoue, M., Ichimiya, T., Takano, A., Nakayama, K., Halldin, C., & Farde, L. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1016 · Cited by 122
GABAergic attenuation of cocaine-induced dopamine release and locomotor activity
Dewey, S. L., Chaurasia, C. S., Chen, C.-E., Volkow, N. D., Clarkson, F. A., Porter, S. P., Straughter-Moore, R. M., Alexoff, D. L., Tedeschi, D., Russo, N. B., et al. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4<393::aid-syn11>3.0.co;2-w · Cited by 119
Deisz, R. A., Billard, J.-M., & Zieglg�nsberger, W. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199701)25:1<62::aid-syn8>3.0.co;2-d · Cited by 112
Self-citationOlsson, H., Halldin, C., & Farde, L. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.02.002 · Cited by 107
Distribution of Dopamine D2-Like Receptors in the Human Thalamus: Autoradiographic and PET Studies
Rieck, R. W., Ansari, M. S., Whetsell, W. O., Deutch, A. Y., & KESSLER, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300336 · Cited by 106
Self-citationGinovart, N., Farde, L., Halldin, C., & Swahn, C.-G. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199704)25:4<321::aid-syn2>3.0.co;2-c · Cited by 105
Changes in somatodendritic but not terminal dopamine regulation in aged rhesus monkeys
Gerhardt, G. A., Cass, W. A., Yi, A., Zhang, Z., & Gash, D. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2001.00684.x · Cited by 102
Tsukada, H., Nishiyama, S., Kakiuchi, T., Ohba, H., Sato, K., & Harada, N. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01834-x · Cited by 100
Talvik, M., Nordström, A.-L., Nyberg, S., Olsson, H., Halldin, C., & Farde, L. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.6.926 · Cited by 98
In Vivo Extrastriatal and Striatal D2 Dopamine Receptor Blockade by Amisulpride in Schizophrenia
Xiberas, X., Martinot, J.-L., Mallet, L., Artiges, E., Canal, M., Loc'h, C., Mazière, B., & Paillère-Martinot, M.-L. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00013 · Cited by 95
Riccardi, P., Zald, D., Li, R., Park, S., Ansari, M. S., Dawant, B., Anderson, S., Woodward, N., Schmidt, D., Baldwin, R., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1639 · Cited by 95
Self-citationTsukada, H., Miyasato, K., Kakiuchi, T., Nishiyama, S., Harada, N., & Domino, E. F. (2002) · Synapse · doi:10.1002/syn.10102 · Cited by 91
Bigliani, V., Mulligan, R. S., Acton, P. D., Ohlsen, R. I., Pike, V. W., Ell, P. J., Gacinovic, S., Kerwin, R. W., & Pilowsky, L. S. (2000) · Psychopharmacology · doi:10.1007/s002130000435 · Cited by 86
Mukherjee, J., Yang, Z.-Y., Lew, R., Brown, T., Kronmal, S., Cooper, M. D., & Seiden, L. S. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<1::aid-syn1>3.0.co;2-9 · Cited by 85
Abi‐Dargham, A., Kegeles, L. S., Martínez, D., Innis, R. B., & Laruelle, M. A. (2003) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2003.08.007 · Cited by 84
Endres, C. J., & Carson, R. E. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00006 · Cited by 82
Bradyphrenia in parkinsonism: a historical review
Rogers, D. (1986) · Psychological Medicine · doi:10.1017/s0033291700009077 · Cited by 82
Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
Kegeles, L. S., Zea-Ponce, Y., Abi-Dargham, A., Rodenhiser, J., Wang, T., Weiss, R., Van Heertum, R. L., Mann, J. J., & Laruelle, M. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4<302::aid-syn9>3.0.co;2-a · Cited by 80
Visualization of extrastriatal dopamine D2 receptors in the human brain
KESSLER, R. M., Mason, N. S., Votaw, J. R., de Paulis, T., Clanton, J. A., Ansari, M. S., Schmidt, D. E., Manning, R. G., & Bell, R. L. (1992) · European Journal of Pharmacology · doi:10.1016/0014-2999(92)90825-o · Cited by 77
Self-citationOptimizing Limbic Selective D2/D3 Receptor Occupancy by Risperidone: A [123I]-Epidepride SPET Study
Bressan, R. A., Erlandsson, K., Jones, H. M., Mulligan, R. S., Ell, P. J., & Pilowsky, L. S. (2003) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200302000-00002 · Cited by 77
KESSLER, R. M., Ansari, M. S., Schmidt, D. E., de Paulis, T., Clanton, J. A., Innis, R. B., Al‐Tikriti, M. S., Manning, R. G., & Gillespie, D. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90261-9 · Cited by 74
Self-citationPhantom validation of coregistration of PET and CT for image‐guided radiotherapy
Lavely, W. C., Scarfone, C., Cevikalp, H., Li, R., Byrne, D. W., Cmelak, A. J., Dawant, B., Price, R. R., Hallahan, D. E., & Fitzpatrick, J. M. (2004) · Medical Physics · doi:10.1118/1.1688041 · Cited by 72
Self-citationSlifstein, M., Narendran, R., Hwang, D., Sudo, Y., Talbot, P. S., Huang, Y., & Laruelle, M. (2004) · Synapse · doi:10.1002/syn.20062 · Cited by 69
Fuxe, K., Rivera, A., Jacobsen, K. X., H�istad, M., Leo, G., Horvath, T. L., Staines, W., De la Calle, A., & Agnati, L. F. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-004-0158-3 · Cited by 68
Moghaddam, B., Berridge, C. W., Goldman‐Rakic, P. S., Bunney, B. S., & Roth, R. H. (1993) · Synapse · doi:10.1002/syn.890130304 · Cited by 64
Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET
Cárdenas, L., Houle, S., Kapur, S., & Busto, U. E. (2004) · Synapse · doi:10.1002/syn.10282 · Cited by 63 · cited 2×
“Recently, Cardenas, using [11C]raclopride PET, reported that an oral dose of 30mg of D-AMPH produced a decrease in striatal b.p. of 13–18% in humans (Cardenas et al, 2004).”
BackgroundInfluentialEffect of endogenous dopamine on extrastriatal [11C]FLB 457 binding measured by PET
Okauchi, T., Suhara, T., Maeda, J., Kawabe, K., Obayashi, S., & Suzuki, K. (2001) · Synapse · doi:10.1002/syn.1063 · Cited by 63
Christian, B. T., Narayanan, T. K., Shi, B., Morris, E. D., Mantil, J., & Mukherjee, J. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000105020.93708.dd · Cited by 62
Chou, Y.-H., Halldin, C., & Farde, L. (2000) · Synapse · doi:10.1002/1098-2396(200011)38:2<138::aid-syn4>3.0.co;2-7 · Cited by 59
Fujita, M., Seibyl, J. P., Verhoeff, N. P. L. G., Ichise, M., Baldwin, R. M., Zoghbi, S. S., Burger, C., Staley, J. K., Rajeevan, N., Charney, D. S., et al. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19991215)34:4<290::aid-syn5>3.0.co;2-b · Cited by 52
Self-citationKerwin, R. W., & Murray, R. M. (1992) · Schizophrenia Research · doi:10.1016/0920-9964(92)90067-f · Cited by 50
Itzhak, Y., Martin, J. L., & Ali, S. F. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19991215)34:4<305::aid-syn6>3.0.co;2-# · Cited by 42
Self-citationPsychosis and the temporal lobe.
Stevens (1991) · PubMed · Cited by 41
Kessler, R. M., Votaw, J. R., de Paulis, T., Bingham, D. R., Ansari, M. S., Mason, N. S., Holburn, G., Schmidt, D. E., Votaw, D. B., Manning, R. G., et al. (1993) · Synapse · doi:10.1002/syn.890150302 · Cited by 40
Self-citationCampíns-Falcó, P., Sevillano-Cabeza, A., Molins-Legua, C., & Kohlmann, M. (1996) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(96)00067-9 · Cited by 37
Townsend, D. W., Isoardi, R., & Bendriem, B. (1998) · Springer eBooks · doi:10.1007/978-94-017-3475-2_4 · Cited by 35
KESSLER, R. M., Votaw, J. R., Schmidt, D. E., Ansari, M. S., Holdeman, K. P., de Paulis, T., Clanton, J. A., Pfeffer, R., Manning, R. G., & Ebert, M. H. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90675-s · Cited by 33
Self-citationDopamine's Reversal of Fortune
Blakely, R. (2001) · Science · doi:10.1126/science.1065931 · Cited by 29
Sequential H(2)(15)O PET studies in baboons: before and after amphetamine.
Price, J. C., Drevets, W. C., Ruszkiewicz, J., Greer, P. J., Villemagne, V. L., Xu, L., Mazumdar, S., Cantwell, M. N., & Mathis, C. A. (2002) · PubMed · Cited by 26
Comparison of three high affinity SPECT radiotracers for the dopamine D2 receptor
Al‐Tikriti, M. S., Baldwin, R. M., Zea‐Ponce, Y., Sybirska, E. H., Zoghbi, S. S., Laruelle, M., Malison, R. T., Kung, H. F., KESSLER, R. M., Charney, D. S., et al. (1994) · Nuclear Medicine and Biology · doi:10.1016/0969-8051(94)90007-8 · Cited by 22
Self-citationAnimal Pharmacology of Raclopride, a Selective Dopamine D2 Antagonist
Hall, H., Ögren, S. O., Köhler, C., & Magnusson, O. (1989) · Springer eBooks · doi:10.1007/978-3-642-74430-3_13 · Cited by 18
KESSLER, R. M., Ansari, M. S., Lui, R., Dawant, B. M., & Meltzer, H. Y. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(03)81249-5 · Cited by 7
Self-citation
Research works printed but not linked: 1
- Mukherjee J, Christian B, Shi B, Narayanan TK, Mantil J (2002). 18F-fallypride displacement in the non- human primate brain by nicotine- induced and amphetamine-induced dopamine release. Neuroimage 16: S42.
Cited by
A review of the clinical pharmacology of methamphetamine
Cruickshank, C. C., & Dyer, K. R. (2009) · Addiction · doi:10.1111/j.1360-0443.2009.02564.x · Cited by 769
del Campo, N., Chamberlain, S. R., Sahakian, B. J., & Robbins, T. W. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.02.036 · Cited by 685
Faraone, S. V. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.02.001 · Cited by 631
“…binding in the striatum of healthy adults, as measured by PET, were correlated with increased cortisol release and positive subjective ratings of AMP Oswald et al. (2015) • AMP decreased [11C]raclopride (a D2 receptor antagonist) binding in the striatum of healthy adults, with lower…”
InfluentialIncreased Synaptic Dopamine Function in Associative Regions of the Striatum in Schizophrenia
Kegeles, L. S., Abi-Dargham, A., Frankle, W. G., Gil, R., Cooper, T. B., Slifstein, M., Hwang, D.-R., Huang, Y., Haber, S. N., & Laruelle, M. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.10 · Cited by 565
Dopaminergic mechanisms of individual differences in human effort-based decision-making
Treadway, M. T., Buckholtz, J. W., Cowan, R. L., Woodward, N. D., Li, R., Ansari, M. S., Baldwin, R. M., Schwartzman, A. N., Kessler, R. M., & Zald, D. H. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6459-11.2012 · Cited by 385
Metadata
- Authors
- Riccardi, P., Li, R., Ansari, M. S., Zald, D., Park, S., Dawant, B., Anderson, S., Doop, M., Woodward, N., Schoenberg, E., Schmidt, D., Baldwin, R., & Kessler, R.
- Affiliations
- Vanderbilt University (US)
- Corresponding author
- Kessler, Robert
- Venue
- Neuropsychopharmacology
- Published
- 2005-10-19
- Volume
- 31
- Issue
- 5
- Pages
- 1016-1026
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2162421322
- Cited by
- 134
- References
- 104
- Citations by year
- 2025: 3 · 2023: 4 · 2022: 3 · 2021: 2 · 2020: 5 · 2019: 2 · 2018: 3 · 2017: 3 · 2016: 12 · 2015: 7 · 2014: 10 · 2013: 12 · 2012: 10
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Mental Health (5R01 MH-60898-03, R01MH060898)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- d-amphetamine, [18F]fallypride, dopamine D2 receptor, dopamine release, striatum, caudate nucleus, putamen, ventral striatum, substantia nigra, amygdala, temporal cortex, thalamus, sensation seeking, cognition, affect, oral administration
- MeSH terms
- Administration, Oral, Adult, Amphetamine, Amygdala, Basal Ganglia, Benzamides, Binding, Competitive, Brain Mapping, Cognition, Corpus Striatum, Dopamine, Emotions, Exploratory Behavior, Female, Humans, Male, Synaptic Transmission, Pyrrolidines, Radionuclide Imaging, Substantia Nigra, Receptors, Dopamine D2, Dopamine Uptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.